Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00992693
Recruitment Status : Enrolling by invitation
First Posted : October 9, 2009
Last Update Posted : May 3, 2018
Valeant Pharmaceuticals International, Inc.
Information provided by (Responsible Party):
U.S. Army Medical Research and Materiel Command

No Study Results Posted on for this Study
  Recruitment Status : Enrolling by invitation
  Actual Primary Completion Date : July 19, 2016
  Estimated Study Completion Date : January 2019